166 related articles for article (PubMed ID: 16472197)
1. Preclinical analyses of the therapeutic potential of allopregnanolone to promote neurogenesis in vitro and in vivo in transgenic mouse model of Alzheimer's disease.
Brinton RD; Wang JM
Curr Alzheimer Res; 2006 Feb; 3(1):11-7. PubMed ID: 16472197
[TBL] [Abstract][Full Text] [Related]
2. The neurosteroid allopregnanolone promotes proliferation of rodent and human neural progenitor cells and regulates cell-cycle gene and protein expression.
Wang JM; Johnston PB; Ball BG; Brinton RD
J Neurosci; 2005 May; 25(19):4706-18. PubMed ID: 15888646
[TBL] [Abstract][Full Text] [Related]
3. Allopregnanolone-induced rise in intracellular calcium in embryonic hippocampal neurons parallels their proliferative potential.
Wang JM; Brinton RD
BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S11. PubMed ID: 19090984
[TBL] [Abstract][Full Text] [Related]
4. Allopregnanolone reverses neurogenic and cognitive deficits in mouse model of Alzheimer's disease.
Wang JM; Singh C; Liu L; Irwin RW; Chen S; Chung EJ; Thompson RF; Brinton RD
Proc Natl Acad Sci U S A; 2010 Apr; 107(14):6498-503. PubMed ID: 20231471
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential of neurogenesis for prevention and recovery from Alzheimer's disease: allopregnanolone as a proof of concept neurogenic agent.
Brinton RD; Wang JM
Curr Alzheimer Res; 2006 Jul; 3(3):185-90. PubMed ID: 16842093
[TBL] [Abstract][Full Text] [Related]
6. Allopregnanolone enhances the neurogenesis of midbrain dopaminergic neurons in APPswe/PSEN1 mice.
Zhang P; Xie MQ; Ding YQ; Liao M; Qi SS; Chen SX; Gu QQ; Zhou P; Sun CY
Neuroscience; 2015 Apr; 290():214-26. PubMed ID: 25637494
[TBL] [Abstract][Full Text] [Related]
7. Regeneration in a degenerating brain: potential of allopregnanolone as a neuroregenerative agent.
Wang JM; Irwin RW; Liu L; Chen S; Brinton RD
Curr Alzheimer Res; 2007 Dec; 4(5):510-7. PubMed ID: 18220513
[TBL] [Abstract][Full Text] [Related]
8. Allopregnanolone as regenerative therapeutic for Alzheimer's disease: translational development and clinical promise.
Irwin RW; Brinton RD
Prog Neurobiol; 2014 Feb; 113():40-55. PubMed ID: 24044981
[TBL] [Abstract][Full Text] [Related]
9. Allopregnanolone promotes regeneration and reduces β-amyloid burden in a preclinical model of Alzheimer's disease.
Chen S; Wang JM; Irwin RW; Yao J; Liu L; Brinton RD
PLoS One; 2011; 6(8):e24293. PubMed ID: 21918687
[TBL] [Abstract][Full Text] [Related]
10. Regenerative potential of allopregnanolone.
Wang JM; Liu L; Irwin RW; Chen S; Brinton RD
Brain Res Rev; 2008 Mar; 57(2):398-409. PubMed ID: 17931704
[TBL] [Abstract][Full Text] [Related]
11. Allopregnanolone restores hippocampal-dependent learning and memory and neural progenitor survival in aging 3xTgAD and nonTg mice.
Singh C; Liu L; Wang JM; Irwin RW; Yao J; Chen S; Henry S; Thompson RF; Brinton RD
Neurobiol Aging; 2012 Aug; 33(8):1493-506. PubMed ID: 21803451
[TBL] [Abstract][Full Text] [Related]
12. Neuroregenerative mechanisms of allopregnanolone in Alzheimer's disease.
Irwin RW; Wang JM; Chen S; Brinton RD
Front Endocrinol (Lausanne); 2011; 2():117. PubMed ID: 22654847
[TBL] [Abstract][Full Text] [Related]
13. Allopregnanolone Promotes Neuronal and Oligodendrocyte Differentiation In Vitro and In Vivo: Therapeutic Implication for Alzheimer's Disease.
Chen S; Wang T; Yao J; Brinton RD
Neurotherapeutics; 2020 Oct; 17(4):1813-1824. PubMed ID: 32632771
[TBL] [Abstract][Full Text] [Related]
14. Allopregnanolone preclinical acute pharmacokinetic and pharmacodynamic studies to predict tolerability and efficacy for Alzheimer's disease.
Irwin RW; Solinsky CM; Loya CM; Salituro FG; Rodgers KE; Bauer G; Rogawski MA; Brinton RD
PLoS One; 2015; 10(6):e0128313. PubMed ID: 26039057
[TBL] [Abstract][Full Text] [Related]
15. Allopregnanolone increases mature excitatory synapses along dendrites via protein kinase A signaling.
Shimizu H; Ishizuka Y; Yamazaki H; Shirao T
Neuroscience; 2015 Oct; 305():139-45. PubMed ID: 26241343
[TBL] [Abstract][Full Text] [Related]
16. Allopregnanolone increases the number of dopaminergic neurons in substantia nigra of a triple transgenic mouse model of Alzheimer's disease.
Sun C; Ou X; Farley JM; Stockmeier C; Bigler S; Brinton RD; Wang JM
Curr Alzheimer Res; 2012 May; 9(4):473-80. PubMed ID: 22272610
[TBL] [Abstract][Full Text] [Related]
17. Modulation of GABA(A) receptor function by neuroactive steroids: evidence for heterogeneity of steroid sensitivity of recombinant GABA(A) receptor isoforms.
Maitra R; Reynolds JN
Can J Physiol Pharmacol; 1998 Sep; 76(9):909-20. PubMed ID: 10066142
[TBL] [Abstract][Full Text] [Related]
18. Antinociceptive effects of the neuroactive steroid, 3alpha-hydroxy-5alpha-pregnan-20-one and progesterone in the land snail, Cepaea nemoralis.
Kavaliers M; Perrot-Sinal TS; Desjardins DC; Cross-Mellor SK; Wiebe JP
Neuroscience; 2000; 95(3):807-12. PubMed ID: 10670448
[TBL] [Abstract][Full Text] [Related]
19. Effects of gintonin-enriched fraction on hippocampal cell proliferation in wild-type mice and an APPswe/PSEN-1 double Tg mouse model of Alzheimer's disease.
Kim HJ; Kim DJ; Shin EJ; Lee BH; Choi SH; Hwang SH; Rhim H; Cho IH; Kim HC; Nah SY
Neurochem Int; 2016 Dec; 101():56-65. PubMed ID: 27765516
[TBL] [Abstract][Full Text] [Related]
20. The inhibitory effects of allopregnanolone and pregnanolone on the population spike, evoked in the rat hippocampal CA1 stratum pyramidale in vitro, can be blocked selectively by epiallopregnanolone.
Wang MD; Bäckström T; Landgren S
Acta Physiol Scand; 2000 Aug; 169(4):333-41. PubMed ID: 10951125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
